GZMB and prostate carcinoma: Numbers of granzyme B+ cells showed a similar trend, with significantly higher numbers in PIN (4.9 ± 2.42), compared to advanced (2.6 ± 1.67) and evanescent prostate carcinoma (2.83 ± 1.85, p = 0.0149) (Figure 9B).